Branched chain amino acid treatment of tardive dyskinesia in children and adolescents. (webmd.com)
In 2009, the FDA issued a warning about the drug's possible side effect, a potentially permanent movement disorder called tardive dyskinesia, which can resemble Tourette's Syndrome or Parkinson's disease. (thedailybeast.com)
Presentations will highlight the short and long - term effects of Ingrezza on tardive dyskinesia symptoms by body region, long term safety and efficacy data from the KINECT 4 phase 3 open label study and also from RE-KINECT (real - world screening study of patients with possible TD). (seekingalpha.com)